Dysregulation of TGFβ signalling is implicated in several diseases and inflammatory pathologies; notably in the context of renal fibrosis, TGFβ1 plays a central role as a pro-fibrotic factor and is pivotal for driving the development and progression of end-stage renal disease. The gene discussed is TGFB1; the disease is stage 5 chronic kidney disease.